BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36203429)

  • 1. Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study.
    Sha M; Chen C; Shen C; Jeong S; Sun HY; Xu N; Hang HL; Cao J; Tong Y
    Front Oncol; 2022; 12():971532. PubMed ID: 36203429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Hong TH; Bae SH; You YK; Choi JY; Yoon SK
    Liver Transpl; 2017 Aug; 23(8):1023-1031. PubMed ID: 28480517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter study.
    Yu J; Zhuang L; Liu P; Liu Z; Ling S; Deng Y; Li J; Yang B; Chen Z; Wang Z; Zang Y; Yang Y; Zheng S; Xu X
    Eur J Surg Oncol; 2022 Jan; 48(1):121-132. PubMed ID: 34456082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein and
    Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
    Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
    Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis.
    Li YN; Wei SM; Fu YK; Zeng ZX; Huang LM; Lv JH; Chen WZ; Wei YG; Zhang ZB; Zhou JY; Wu JY; Yan ML
    Front Oncol; 2024; 14():1372123. PubMed ID: 38628666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
    Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
    Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?
    Ma KW; Chan ACY; Chok KSH; She WH; Cheung TT; Dai WC; Fung JYY; Lo CM
    Hepatobiliary Surg Nutr; 2021 Jun; 10(3):308-314. PubMed ID: 34159158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study.
    Zhang XP; Zhou TF; Feng JK; Sun ZY; Zhen ZJ; Zhou D; Zhang F; Hu YR; Zhong CQ; Chen ZH; Chai ZT; Wang K; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
    Front Oncol; 2021; 11():697073. PubMed ID: 34395264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy.
    Chai ZT; Zhang XP; Shao M; Ao JY; Chen ZH; Zhang F; Hu YR; Zhong CQ; Lin JH; Fang KP; Wu MC; Lau WY; Cheng SQ
    Ann Transl Med; 2021 Feb; 9(3):247. PubMed ID: 33708874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Yuan G; Cheng X; Li Q; Zang M; Huang W; Fan W; Wu T; Ruan J; Dai W; Yu W; Chen M; Guo Y; Hu X; Chen J
    Onco Targets Ther; 2020; 13():12683-12693. PubMed ID: 33328740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
    World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
    Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy.
    Ji M; Zou H; Shu B; Liu G; Zhang B; Xu Z; Pang F; Cheng M; Sun Y; Du T; Sun C; Zhu C
    Front Surg; 2022; 9():1042431. PubMed ID: 36420403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
    Zhang XP; Gao YZ; Chen ZH; Chen MS; Li LQ; Wen TF; Xu L; Wang K; Chai ZT; Guo WX; Shi J; Xie D; Wu MC; Yee Lau W; Cheng SQ
    Hepatology; 2019 May; 69(5):2076-2090. PubMed ID: 30586158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.
    Qi LN; Ma L; Wu FX; Chen YY; Xing WT; Jiang ZJ; Zhong JH; Chen ZS; Gong WF; Ye JZ; Li HH; Shang JJ; Xiang BD; Li LQ
    Hepatol Int; 2021 Feb; 15(1):114-126. PubMed ID: 33495903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.